TRACON Pharmaceuticals Inc (TCON)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Charles P. Theuer
Employees:
20
4350 LA JOLLA VILLAGE DRIVE, SUITE 800, San Diego, CA 92122
858-550-0780

TRACON Pharmaceuticals, Inc. focuses on the development and commercialization of therapeutics for cancer in the United States. Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of soft tissue sarcoma; and YH001, an investigational humanized CTLA-4 IgG1 monoclonal antibody. TRC102, a small molecule that is in Phase II clinical trial for the. treatment of mesothelioma, and in Phase I clinical trial to treat solid tumors and lymphomas, lung cancer, and gliob

Data derived from most recent annual or quarterly report
Market Cap 13.722 Million Shares Outstanding23.823 Million Avg 30-day Volume 90.941 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.27
Price to Revenue0.0 Debt to Equity0.0 EBITDA-24.346 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value38.187 Million
Current Ratio0.503 EPS Growth0.249 Quick Ratio0.466
1 Yr BETA 0.997 52-week High/Low 2.32 / 0.57 Profit Margin0.0
Operating Cash Flow Growth-0.1881 Altman Z-Score-51.2233 Free Cash Flow to Firm -13.503 Million
Earnings Report2023-08-09
View SEC Filings from TCON instead.

View recent insider trading info

TRACON Pharmaceuticals Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding TCON (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TCON

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-04-28 by THEUER CHARLES
  • 4: filed on 2023-04-21 by JOHNSON-PRATT LISA
  • 4: filed on 2023-04-21 by LAM CAROL C.
  • 4: filed on 2023-04-21 by PELLETIER SAUNDRA L
  • 4: filed on 2023-04-21 by MATTINGLY MARTIN A
  • 4: filed on 2023-04-21 by WORLAND STEPHEN T
  • 4: filed on 2023-04-21 by LARUE WILLIAM R
  • 4: filed on 2023-04-21 by TWIFORD J RAINER
  • 4: filed on 2023-03-02 by THEUER CHARLES
  • 4: filed on 2023-02-03 by THEUER CHARLES

    • Events (8k)

  • 8-K: filed on 2023-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-04:
    Item 1.02: Termination of a Material Definitive Agreement
  • 8-K: filed on 2023-04-25:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-06:
    Item 1.01: Entry into a Material Definitive Agreement
  • 8-K: filed on 2023-03-31:
    Item 8.01: Other Events
  • 8-K: filed on 2023-03-15:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
  • 8-K: filed on 2023-03-09:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-24:
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    51 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    THEUER CHARLES PRESIDENT AND CEO

    • Officer
    • Director
    		 399,417 2023-04-26 13

    PELLETIER SAUNDRA L

    • Director
    		 0 2023-04-19 2

    MATTINGLY MARTIN A

    • Director
    		 0 2023-04-19 2

    LARUE WILLIAM R

    • Director
    		 0 2023-04-19 3

    WORLAND STEPHEN T

    • Director
    		 0 2023-04-19 2

    TWIFORD J RAINER

    • Director
    		 0 2023-04-19 2

    LAM CAROL C.

    • Director
    		 0 2023-04-19 2

    JOHNSON-PRATT LISA

    • Director
    		 0 2023-04-19 2

    OPALEYE MANAGEMENT INC.

    • 10% Owner
    		 4,324,508 2023-03-09 14

    BROWN SCOTT B. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-02-01 3

    ADAMS BONNE J. CHIEF OPERATING OFFICER

    • Officer
    		 4,267 2023-02-01 2

    WIGGINS MARK C CHIEF BUSINESS OFFICER

    • Officer
    		 80,000 2022-01-28 0

    IKARIAN CAPITAL, LLC

    IKARIAN HEALTHCARE MASTER FUND, L.P.

    IKARIAN HEALTHCARE FUND GP, L.P.

    CHART WESTCOTT LIVING TRUST

    SHAHRESTANI NEIL

    • 10% Owner
    • MEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUP
    		 2,716,840 2020-12-30 0

    IKARIAN CAPITAL, LLC

    IKARIAN HEALTHCARE MASTER FUND, L.P.

    SHAHRESTANI NEIL

    • 10% Owner
    • MEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUP
    		 2,162,549 2020-09-04 0

    IKARIAN CAPITAL, LLC

    • 10% Owner
    • MEMBER OF 10% GROUP
    		 1,840,078 2020-09-03 0

    CHART WESTCOTT LIVING TRUST

    IKARIAN HEALTHCARE MASTER FUND, L.P.

    IKARIAN HEALTHCARE FUND GP, L.P.

    SHAHRESTANI NEIL

    • 10% Owner
    • MEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUPMEMBER OF 10% GROUP
    		 1,840,078 2020-09-03 0

    WALKER PAUL EDWARD

    • Director
    		 0 2020-06-10 0

    PUISSANCE CROSS-BORDER OPPORTUNITIES V LLC

    PUISSANCE CROSS-BORDER OPPORTUNITIES IV LLC

    PUISSANCE CAPITAL MANAGEMENT LP

    PUISSANCE CAPITAL FUND (GP) LLC

    PUISSANCE CAPITAL MANAGEMENT (GP) LLC

    WANG THEODORE T

    • 10% Owner
    		 No longer subject to file 2019-12-05 0

    PUISSANCE CROSS-BORDER OPPORTUNITIES V LLC

    PUISSANCE CROSS-BORDER OPPORTUNITIES IV LLC

    PUISSANCE LIFE SCIENCE OPPORTUNITIES FUND VI

    PUISSANCE CAPITAL MANAGEMENT LP

    PUISSANCE CAPITAL MANAGEMENT (GP) LLC

    PUISSANCE CAPITAL FUND (GP) LLC

    WANG THEODORE T

    • Director
    • 10% Owner
    		 9,207,862 2018-11-29 0

    WANG THEODORE T

    • Director
    • 10% Owner
    		 0 2018-06-13 0

    BARRIS PETER J

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    BARRETT M JAMES

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    MOTT DAVID M

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    KERINS PATRICK J

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    SANDELL SCOTT D

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    BASKETT FOREST

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    VISWANATHAN RAVI

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    NEW ENTERPRISE ASSOCIATES 14, L.P.

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    SONSINI PETER W.

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    FLORENCE ANTHONY A. JR.

    NEA PARTNERS 14, L.P.

    NEA 14 GP, LTD

    • 10% Owner
    		 4,173,967 2018-03-27 0

    BITAR PATRICIA L CFO

    • Officer
    		 0 2018-02-21 0

    LOGAN H CASEY CHIEF BUSINESS OFFICER

    • Officer
    		 27,754 2018-01-22 0

    BARRIS PETER J

    • 10% Owner
    		 2,758,039 2016-11-29 0

    BARRETT M JAMES

    • 10% Owner
    		 2,758,039 2016-11-29 0

    MOTT DAVID M

    • 10% Owner
    		 2,758,039 2016-11-29 0

    KERINS PATRICK J

    • 10% Owner
    		 2,758,039 2016-11-29 0

    SANDELL SCOTT D

    • 10% Owner
    		 2,758,039 2016-11-29 0

    KOLLURI KRISHNA KITTU

    • 10% Owner
    		 2,758,039 2016-11-29 0

    BASKETT FOREST

    • 10% Owner
    		 2,758,039 2016-11-29 0

    VISWANATHAN RAVI

    • 10% Owner
    		 2,758,039 2016-11-29 0

    SONSINI PETER W.

    • 10% Owner
    		 2,758,039 2016-11-29 0

    FLORENCE ANTHONY A. JR.

    • 10% Owner
    		 2,758,039 2016-11-29 0

    SHAZER RONALD L CHIEF MEDICAL OFFICER

    • Officer
    		 335 2016-06-03 0

    JAFCO SUPER V3 INVESTMENT LIMITED PARTNERSHIP

    • 10% Owner
    		 1,497,053 2015-10-16 0

    BROOKLINE TRACON INVESTMENT FUND II, LLC

    BROOKLINE TRACON INVESTMENT FUND LLC

    CSA BIOTECHNOLOGY FUND I, LLC

    CSA BIOTECHNOLOGY FUND II, LLC

    • 10% Owner
    		 No longer subject to file 2015-07-30 0

    DRANT RYAN D

    • 10% Owner
    		 1,888,474 2015-02-04 0

    WELLER HARRY R

    • 10% Owner
    		 1,888,474 2015-02-04 0

    HOZOJI HIRONORI

    • Director
    		 0 2015-01-29 0

    BROOKLINE TRACON INVESTMENT FUND II, LLC

    CSA BIOTECHNOLOGY FUND II, LLC

    • 10% Owner
    		 580,050 2015-01-29 0

    HARADA KENJI

    • Director
    		 0 2015-01-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    THEUER CHARLES - Director - Officer PRESIDENT AND CEO

    		2023-04-28 06:00:11 -0400 2023-04-27 P 47,000 $0.75 a 399,417 direct -2.6616 -8.7452 0.0 1 -12.0406 3

    THEUER CHARLES - Director - Officer PRESIDENT AND CEO

    		2023-04-28 06:00:11 -0400 2023-04-26 P 3,999 $0.66 a 352,417 direct -2.6616 -8.7452 0.0 1 -12.0406 3

    TWIFORD J RAINER - Director

    		2023-04-21 20:36:31 -0400 2023-04-19 A 18,000 a 18,000 direct

    LARUE WILLIAM R - Director

    		2023-04-21 20:37:53 -0400 2023-04-19 A 18,000 a 18,000 direct

    WORLAND STEPHEN T - Director

    		2023-04-21 20:41:50 -0400 2023-04-19 A 18,000 a 18,000 direct

    MATTINGLY MARTIN A - Director

    		2023-04-21 20:44:49 -0400 2023-04-19 A 18,000 a 18,000 direct

    PELLETIER SAUNDRA L - Director

    		2023-04-21 20:48:32 -0400 2023-04-19 A 18,000 a 18,000 direct

    LAM CAROL C. - Director

    		2023-04-21 20:52:54 -0400 2023-04-19 A 18,000 a 18,000 direct

    JOHNSON-PRATT LISA - Director

    		2023-04-21 20:55:25 -0400 2023-04-19 A 18,000 a 18,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 22:15:04 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 21:45:04 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 21:15:03 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 20:45:04 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 20:15:06 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 19:45:04 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 19:15:21 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 18:45:03 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 18:15:04 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 17:45:03 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 17:15:05 UTC 3.1698 1.8902 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 16:45:04 UTC 3.1604 1.9096 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 16:15:04 UTC 3.1604 1.9096 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 15:45:03 UTC 3.1604 1.9096 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 15:15:04 UTC 3.1604 1.9096 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 14:45:04 UTC 3.1604 1.9096 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 14:15:03 UTC 3.1604 1.9096 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 13:45:04 UTC 2.9615 2.1085 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 13:15:04 UTC 2.9615 2.1085 750000
    TRACON PHARMACEUTICALS INC TCON 2023-05-31 12:45:04 UTC 2.9615 2.1085 750000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments